Results
1 -
10 of
107Susanne Kern, Rebekka Baumgartner, Damian E. Helbling, Juliane Hollender, Heinz Singer, Martin J. Loos, René P. Schwarzenbach and Kathrin Fenner.
A tiered procedure for assessing the formation of biotransformation products of pharmaceuticals and biocides during activated sludge treatment, J. Environ. Monit., 2010, 12, 2100. Frank Sacher, Melanie Ehmann, Sabine Gabriel, Carola Graf and Heinz-Jürgen Brauch.
Pharmaceutical residues in the river Rhine—results of a one-decade monitoring programme, J. Environ. Monit., 2008, 10, 664. Araceli Garcia-Ac, Pedro A. Segura, Christian Gagnon and Sébastien Sauvé.
Determination of bezafibrate, methotrexate, cyclophosphamide, orlistat and enalapril in waste and surface waters using on-line solid-phase extractionliquid chromatography coupled to polarity-switching electrospray tandem mass spectrometry, J. Environ. Monit., 2009, 11, 830. Qiuxin Huang, Yiyi Yu, Caiming Tang, Kun Zhang, Jianlan Cui and Xianzhi Peng.
Occurrence and behavior of non-steroidal anti-inflammatory drugs and lipid regulators in wastewater and urban river water of the Pearl River Delta, South China, J. Environ. Monit., 2011, 13, 855. Rosiglitazone and bezafibrate modulate gene expression in a rat model of non-alcoholic fatty liver disease - A historical prospective, Lipids in Health and Disease Investigation of novel material for effective photodegradation of bezafibrate in aqueous samples, Environmental Science and Pollution Research Effect of a pharmacological activation of PPAR on the expression of RAR and TR in rat liver, Journal of Physiology and Biochemistry